These findings are in keeping with level I studies29,30 that supported the role of ERAS in ovarian cancer debulking, despite the fact that a recent survey31 of gynecologic oncologists found low ERAS uptake in cytoreductive surgery. This evidence concerns the gene ERAS and ovarian cancer.